Sundram Fasteners Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 18, 2025, 3:20 am

Competitors of Sundram Fasteners Ltd

All Competitor Stocks of Sundram Fasteners Ltd

Quarterly Result

Last Updated: August 1, 2025, 10:55 am

Below is a detailed analysis of the quarterly data for Sundram Fasteners Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,533.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,531.00 Cr. (Mar 2025) to 1,533.00 Cr., marking an increase of 2.00 Cr..
• For Expenses, as of Jun 2025, the value is 1,286.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,306.00 Cr. (Mar 2025) to 1,286.00 Cr., marking a decrease of 20.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 247.00 Cr.. The value appears strong and on an upward trend. It has increased from 225.00 Cr. (Mar 2025) to 247.00 Cr., marking an increase of 22.00 Cr..
• For OPM %, as of Jun 2025, the value is 16.00%. The value appears strong and on an upward trend. It has increased from 15.00% (Mar 2025) to 16.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 13.00 Cr..
• For Interest, as of Jun 2025, the value is 9.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 59.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 58.00 Cr. (Mar 2025) to 59.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 199.00 Cr.. The value appears strong and on an upward trend. It has increased from 164.00 Cr. (Mar 2025) to 199.00 Cr., marking an increase of 35.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Mar 2025) to 26.00%, marking an increase of 2.00%.
• For Net Profit, as of Jun 2025, the value is 148.00 Cr.. The value appears strong and on an upward trend. It has increased from 124.00 Cr. (Mar 2025) to 148.00 Cr., marking an increase of 24.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 7.06. The value appears strong and on an upward trend. It has increased from 5.92 (Mar 2025) to 7.06, marking an increase of 1.14.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:22 am

Growth

Last Updated: September 5, 2025, 1:36 pm

Balance Sheet

Last Updated: November 9, 2025, 3:02 pm

Below is a detailed analysis of the balance sheet data for Sundram Fasteners Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 21.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 21.00 Cr..
• For Reserves, as of Sep 2025, the value is 4,030.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,789.00 Cr. (Mar 2025) to 4,030.00 Cr., marking an increase of 241.00 Cr..
• For Borrowings, as of Sep 2025, the value is 741.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 823.00 Cr. (Mar 2025) to 741.00 Cr., marking a decrease of 82.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 909.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 893.00 Cr. (Mar 2025) to 909.00 Cr., marking an increase of 16.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 5,701.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,527.00 Cr. (Mar 2025) to 5,701.00 Cr., marking an increase of 174.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 2,358.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,253.00 Cr. (Mar 2025) to 2,358.00 Cr., marking an increase of 105.00 Cr..
• For CWIP, as of Sep 2025, the value is 167.00 Cr.. The value appears to be declining and may need further review. It has decreased from 196.00 Cr. (Mar 2025) to 167.00 Cr., marking a decrease of 29.00 Cr..
• For Investments, as of Sep 2025, the value is 141.00 Cr.. The value appears strong and on an upward trend. It has increased from 120.00 Cr. (Mar 2025) to 141.00 Cr., marking an increase of 21.00 Cr..
• For Other Assets, as of Sep 2025, the value is 3,035.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,957.00 Cr. (Mar 2025) to 3,035.00 Cr., marking an increase of 78.00 Cr..
• For Total Assets, as of Sep 2025, the value is 5,701.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,527.00 Cr. (Mar 2025) to 5,701.00 Cr., marking an increase of 174.00 Cr..

Notably, the Reserves (4,030.00 Cr.) exceed the Borrowings (741.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Sundram Fasteners Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 25.66. This value is within the healthy range. It has increased from 24.83 (Mar 24) to 25.66, marking an increase of 0.83.
• For Diluted EPS (Rs.), as of Mar 25, the value is 25.66. This value is within the healthy range. It has increased from 24.83 (Mar 24) to 25.66, marking an increase of 0.83.
• For Cash EPS (Rs.), as of Mar 25, the value is 36.44. This value is within the healthy range. It has increased from 35.17 (Mar 24) to 36.44, marking an increase of 1.27.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 181.36. It has increased from 163.79 (Mar 24) to 181.36, marking an increase of 17.57.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 181.36. It has increased from 163.79 (Mar 24) to 181.36, marking an increase of 17.57.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 283.46. It has increased from 269.70 (Mar 24) to 283.46, marking an increase of 13.76.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 46.29. This value is within the healthy range. It has increased from 44.78 (Mar 24) to 46.29, marking an increase of 1.51.
• For PBIT / Share (Rs.), as of Mar 25, the value is 35.63. This value is within the healthy range. It has increased from 34.63 (Mar 24) to 35.63, marking an increase of 1.00.
• For PBT / Share (Rs.), as of Mar 25, the value is 34.03. This value is within the healthy range. It has increased from 33.11 (Mar 24) to 34.03, marking an increase of 0.92.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 25.79. This value is within the healthy range. It has increased from 25.02 (Mar 24) to 25.79, marking an increase of 0.77.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 25.66. This value is within the healthy range. It has increased from 24.83 (Mar 24) to 25.66, marking an increase of 0.83.
• For PBDIT Margin (%), as of Mar 25, the value is 16.32. This value is within the healthy range. It has decreased from 16.60 (Mar 24) to 16.32, marking a decrease of 0.28.
• For PBIT Margin (%), as of Mar 25, the value is 12.56. This value is within the healthy range. It has decreased from 12.83 (Mar 24) to 12.56, marking a decrease of 0.27.
• For PBT Margin (%), as of Mar 25, the value is 12.00. This value is within the healthy range. It has decreased from 12.27 (Mar 24) to 12.00, marking a decrease of 0.27.
• For Net Profit Margin (%), as of Mar 25, the value is 9.09. This value is within the healthy range. It has decreased from 9.27 (Mar 24) to 9.09, marking a decrease of 0.18.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 9.05. This value is within the healthy range. It has decreased from 9.20 (Mar 24) to 9.05, marking a decrease of 0.15.
• For Return on Networth / Equity (%), as of Mar 25, the value is 14.14. This value is below the healthy minimum of 15. It has decreased from 15.25 (Mar 24) to 14.14, marking a decrease of 1.11.
• For Return on Capital Employeed (%), as of Mar 25, the value is 18.23. This value is within the healthy range. It has decreased from 19.63 (Mar 24) to 18.23, marking a decrease of 1.40.
• For Return On Assets (%), as of Mar 25, the value is 9.75. This value is within the healthy range. It has decreased from 10.45 (Mar 24) to 9.75, marking a decrease of 0.70.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. It has increased from 0.18 (Mar 24) to 0.20, marking an increase of 0.02.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.13. It has decreased from 1.18 (Mar 24) to 1.13, marking a decrease of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 1.94. This value is within the healthy range. It has increased from 1.86 (Mar 24) to 1.94, marking an increase of 0.08.
• For Quick Ratio (X), as of Mar 25, the value is 1.19. This value is within the healthy range. It has increased from 1.13 (Mar 24) to 1.19, marking an increase of 0.06.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.44. This value is below the healthy minimum of 4. It has decreased from 2.54 (Mar 24) to 2.44, marking a decrease of 0.10.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 27.94. This value is within the healthy range. It has increased from 23.11 (Mar 24) to 27.94, marking an increase of 4.83.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 19.74. This value is below the healthy minimum of 20. It has increased from 16.40 (Mar 24) to 19.74, marking an increase of 3.34.
• For Earning Retention Ratio (%), as of Mar 25, the value is 72.06. This value exceeds the healthy maximum of 70. It has decreased from 76.89 (Mar 24) to 72.06, marking a decrease of 4.83.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 80.26. This value exceeds the healthy maximum of 70. It has decreased from 83.60 (Mar 24) to 80.26, marking a decrease of 3.34.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 28.99. This value is within the healthy range. It has decreased from 29.41 (Mar 24) to 28.99, marking a decrease of 0.42.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 17.15. This value is within the healthy range. It has decreased from 17.43 (Mar 24) to 17.15, marking a decrease of 0.28.
• For Enterprise Value (Cr.), as of Mar 25, the value is 19,986.40. It has decreased from 23,564.32 (Mar 24) to 19,986.40, marking a decrease of 3,577.92.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.36. This value exceeds the healthy maximum of 3. It has decreased from 4.16 (Mar 24) to 3.36, marking a decrease of 0.80.
• For EV / EBITDA (X), as of Mar 25, the value is 20.55. This value exceeds the healthy maximum of 15. It has decreased from 25.05 (Mar 24) to 20.55, marking a decrease of 4.50.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.23. This value exceeds the healthy maximum of 3. It has decreased from 4.05 (Mar 24) to 3.23, marking a decrease of 0.82.
• For Retention Ratios (%), as of Mar 25, the value is 72.05. This value exceeds the healthy maximum of 70. It has decreased from 76.88 (Mar 24) to 72.05, marking a decrease of 4.83.
• For Price / BV (X), as of Mar 25, the value is 5.04. This value exceeds the healthy maximum of 3. It has decreased from 6.71 (Mar 24) to 5.04, marking a decrease of 1.67.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.23. This value exceeds the healthy maximum of 3. It has decreased from 4.05 (Mar 24) to 3.23, marking a decrease of 0.82.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness